Skip to main content
Year archive

Aptabio Therapeutics Inc. — 2019 filings

All 14 regulatory filings released by Aptabio Therapeutics Inc. (293780) in 2019, sourced directly from the official regulator.

14 Filings
2019 Period
2019 filings (14)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2019-12-16 Korean
분기보고서 (2019.09)
Interim / Quarterly Report 9M 2019
2019-11-14 Korean
반기보고서 (2019.06)
Interim / Quarterly Report H1 2019
2019-08-14 Korean
기타경영사항(특허권취득)(자율공시)(신규한 양이온 리피드를 포함하는 유전자 전달체)
Regulatory Filings
2019-08-05 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2019-06-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2019-06-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-06-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-06-17 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2019-06-14 Korean
증권발행실적보고서
Capital/Financing Update
2019-06-10 Korean
투자설명서
Proxy Solicitation & Information Statement
2019-05-27 Korean
증권신고서(지분증권)
Regulatory Filings
2019-05-02 Korean
분기보고서 (2019.03)
Interim / Quarterly Report Q1 2019
2019-04-26 Korean
사업보고서 (2018.12)
Annual Report FY 2018
2019-03-22 Korean